{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T23:08:19Z","timestamp":1778454499307,"version":"3.51.4"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>The liver is frequently exposed to acute and chronic insults that disrupt its function, leading to inflammation, fibrosis, and serious conditions like cirrhosis and hepatocellular carcinoma. Fibrosis, driven by the activation of hepatic stellate cells is a key feature of chronic liver damage. Traditional 2D liver models face limitations in maintaining liver functions and accurately replicating chronic conditions like fibrosis. In response to these needs, 3D models have emerged as more physiologically relevant platforms for studying liver disease and drug testing. However, most existing 3D models still lack chronic injury features or immune elements. In this study, we developed a 3D human-liver model to investigate both acute and chronic drug-induced liver injury. The model consists of encapsulated human hepatocytes (HepaRG) and hepatic stellate cells (LX-2) within a gelatin methacryloyl (GelMA) and carboxymethyl cellulose methacrylate matrix. Over a 30-day culture period, the 3D liver constructs maintained physiologically relevant functions, including albumin secretion and cytochrome P450 activity, which are lost rapidly in conventional 2D models. The model enabled reliable simulation of low-level, long-term, and high-dose, short-term damage by administering lipopolysaccharide and Paracetamol. Chronic liver injury was characterized by progressive fibrosis, elevated expression of COL1A1, and persistent hyperammonemia. In contrast, acute models showed significant but transient injury. Moreover, dexamethasone treatment successfully reversed fibrotic markers and restored hepatocyte functionality, indicating the model\u2019s predictive power for evaluating potential therapies. Incorporating human monocytes (THP-1) allowed investigation of the immune response and macrophage activation, which are critical contributors to liver disease pathogenesis. Overall, this 3D liver model offers a physiologically relevant and versatile platform for studying complex multi-cellular interactions under acute and chronic injury. It has broad implications for drug safety screening, disease modeling, and personalized therapy. The tri-culture design extends the model\u2019s capacity to elucidate immune-driven hepatic pathology.<\/jats:p>","DOI":"10.3389\/fbioe.2026.1798323","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:10:16Z","timestamp":1778451016000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A 3D bioengineered human liver for the study of acute and chronic drug-induced hepatotoxicity and fibrosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Ainhoa","family":"Ferret-Mi\u00f1ana","sequence":"first","affiliation":[{"name":"Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC)","place":["Barcelona, Spain"]},{"name":"Universitat de Barcelona (UB)","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estefan\u00eda","family":"Alcaraz","sequence":"additional","affiliation":[{"name":"Scientific Innovation Office, Grifols","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Horrillo","sequence":"additional","affiliation":[{"name":"Scientific Innovation Office, Grifols","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ram\u00f3n-Azc\u00f3n","sequence":"additional","affiliation":[{"name":"Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC)","place":["Barcelona, Spain"]},{"name":"ICREA-Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"De Chiara","sequence":"additional","affiliation":[{"name":"Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC)","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7873","DOI":"10.3390\/ijms25147873","article-title":"Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells","volume":"7873","author":"Akk\u0131z","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"G391","DOI":"10.1152\/ajpgi.00072.2023","article-title":"Albumin and fibrinogen synthesis rates in advanced chronic liver disease","volume":"325","author":"Amouzandeh","year":"2023","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/bs.apha.2022.05.009","article-title":"Expression and functional activity of cytochrome P450 enzymes in human hepatocytes with sustainable reproducibility for in vitro phenotyping studies","volume":"95","author":"Bachour-El Azzi","year":"2022","journal-title":"Adv. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"25187","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"25187","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1042\/CS20050222","article-title":"Synthesis rates of total liver protein and albumin are both increased in patients with an acute inflammatory response","volume":"110","author":"Barle","year":"2006","journal-title":"Clin. Sci. (Lond)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1377136","article-title":"Mouse liver sinusoidal endothelial cell responses to the glucocorticoid receptor agonist dexamethasone","volume":"15","author":"Bhandari","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1002\/bit.27379","article-title":"Differential fibrotic phenotypes of hepatic stellate cells within 3D liver organoids","volume":"117","author":"Brovold","year":"2020","journal-title":"Biotechnol. Bioeng."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e10207","DOI":"10.1002\/btm2.10207","article-title":"Biofabricated 3D in vitro model of fibrosis-induced abnormal hepatoblast\/biliary progenitors' expansion of the developing liver","volume":"6","author":"Brovold","year":"2021","journal-title":"Bioeng. Transl. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/biomedicines10050958","article-title":"Fatty hepatocytes induce skeletal muscle atrophy in vitro: a new 3D platform to study the protective effect of albumin in non-alcoholic fatty liver","volume":"958","author":"De Chiara","year":"2022","journal-title":"Biomedicines"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1111\/liv.14205","article-title":"Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion","volume":"39","author":"Eriksen","year":"2019","journal-title":"Liver Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1800167","DOI":"10.1002\/mabi.201800167","article-title":"Composite biomaterials as long-lasting scaffolds for 3d bioprinting of highly aligned muscle tissue","volume":"18","author":"Garc\u00eda-Lizarribar","year":"2018","journal-title":"Macromol. Biosci."},{"key":"B8","doi-asserted-by":"crossref","first-page":"21868","DOI":"10.1038\/srep21868","article-title":"Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model","volume":"6","author":"Gr\u00f6ger","year":"2016","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13578-024-01317-2","article-title":"Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques","volume":"134","author":"Guo","year":"2024","journal-title":"Cell Biosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12876-022-02213-0","article-title":"Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency","volume":"144","author":"Imoto","year":"2022","journal-title":"BMC Gastroenterol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/labinvest.2009.51","article-title":"Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis","volume":"89","author":"Ma","year":"2009","journal-title":"Lab. Invest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0234441","DOI":"10.1371\/journal.pone.0234441","article-title":"3D culture of functional human iPSC-derived hepatocytes using a core-shell microfiber","volume":"15","author":"Nagata","year":"2020","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1872-034X.2007.00076.x","article-title":"Cirrhosis and endotoxin decrease urea synthesis in rats","volume":"37","author":"Nielsen","year":"2007","journal-title":"Hepatol. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s00204-017-2002-1","article-title":"Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury","volume":"91","author":"Proctor","year":"2017","journal-title":"Arch. Toxicol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1055\/s-2008-1073116","article-title":"Acute liver failure: mechanisms of hepatocyte injury and regeneration","volume":"28","author":"Rutherford","year":"2008","journal-title":"Semin. Liver Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"154248","DOI":"10.1016\/j.tox.2025.154248","article-title":"A high-throughput microphysiological system to quantify key events leading to liver fibrosis","volume":"518","author":"Schmidt","year":"2025","journal-title":"Toxicology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"626805","DOI":"10.3389\/fcell.2021.626805","article-title":"A critical perspective on 3D liver models for drug metabolism and toxicology studies","volume":"9","author":"Serras","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1038\/s41467-024-49332-8","article-title":"Transient growth factor expression via mRNA in lipid nanoparticles promotes hepatocyte cell therapy in mice","volume":"5010","author":"Smith","year":"2024","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3390\/biomedicines12102229","article-title":"Liver fibrosis leading to cirrhosis: basic mechanisms and clinical perspectives","volume":"2229","author":"Somnay","year":"2024","journal-title":"Biomedicines"},{"key":"B18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000444557","article-title":"Acute liver failure - it's just a matter of cell death","volume":"34","author":"Sowa","year":"2016","journal-title":"Dig. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"153829","DOI":"10.1016\/j.tox.2024.153829","article-title":"A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction","volume":"505","author":"Sun","year":"2024","journal-title":"Toxicology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2021.605392","article-title":"Recent advances in models of immune-mediated drug-induced liver injury","volume":"3","author":"Tasnim","year":"2021","journal-title":"Front. Toxicol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1061453","DOI":"10.3389\/fpubh.2023.1061453","article-title":"Global, regional, and national burden of 10 digestive diseases in 204 countries and territories from 1990 to 2019","volume":"11","author":"Wang","year":"2023","journal-title":"Front. Public Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fphar.2014.00167","article-title":"The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies","volume":"167","author":"Xu","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"100432","DOI":"10.1016\/j.crmeth.2023.100432","article-title":"Liver three-dimensional cellular models for high-throughput chemical testing","volume":"3","author":"Yang","year":"2023","journal-title":"Cell Rep. Methods"},{"key":"B23","first-page":"289","article-title":"Comprehensive evaluation of organotypic and microphysiological liver models for predicting drug-induced liver injury","volume":"155","author":"Zhou","year":"2019","journal-title":"Toxicol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/BF02722948","article-title":"Characterization of a primary hepatocyte culture system for toxicological studies","volume":"32","author":"Zurlo","year":"1996","journal-title":"Vitro Cell Dev. Biol. Anim."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2026.1798323\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:10:18Z","timestamp":1778451018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2026.1798323\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":33,"alternative-id":["10.3389\/fbioe.2026.1798323"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2026.1798323","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"article-number":"1798323"}}